U.K. Regulator’s Echinacea Action Sends Chills Through U.S. Industry
This article was originally published in The Tan Sheet
Executive Summary
While the risk of an allergic reaction to Echinacea in children under 12 is minimal, the U.K. medicines regulator sends a message to consumers that the age group should not take the supplement, and will require manufacturers to include warning labels.